CNBC World

Court rules companies can't import Gilead medications from overseas in blow to AFP health programs

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

French court blocks Macron’s social media ban for under-15sWorldPing
The Guardian

French court blocks Macron’s social media ban for under-15s

Constitutional council says curbs infringe freedom of expression and privacy as president vows to rework legislation France’s top court has blocked a ban on social media access for under-15s, ruling that it infringed freedom of expression and privacy.

Brief by WorldPing · Original reporting by The Guardian